ZA929867B - New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs - Google Patents
New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugsInfo
- Publication number
- ZA929867B ZA929867B ZA929867A ZA929867A ZA929867B ZA 929867 B ZA929867 B ZA 929867B ZA 929867 A ZA929867 A ZA 929867A ZA 929867 A ZA929867 A ZA 929867A ZA 929867 B ZA929867 B ZA 929867B
- Authority
- ZA
- South Africa
- Prior art keywords
- hypolipidemic
- ether compounds
- new
- antiatherosclerotic drugs
- antiatherosclerotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/810,214 US5254549A (en) | 1991-12-19 | 1991-12-19 | New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA929867B true ZA929867B (en) | 1994-06-20 |
Family
ID=25203281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA929867A ZA929867B (en) | 1991-12-19 | 1992-12-18 | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
Country Status (16)
Country | Link |
---|---|
US (1) | US5254549A (cs) |
EP (1) | EP0619807A1 (cs) |
JP (1) | JPH07502271A (cs) |
AU (1) | AU662193B2 (cs) |
CA (1) | CA2085687A1 (cs) |
CZ (1) | CZ283456B6 (cs) |
FI (1) | FI942908A0 (cs) |
HU (1) | HU215844B (cs) |
IL (1) | IL104123A (cs) |
MX (1) | MX9207427A (cs) |
NO (1) | NO301473B1 (cs) |
PL (1) | PL171225B1 (cs) |
RU (1) | RU2120938C1 (cs) |
TW (1) | TW221289B (cs) |
WO (1) | WO1993012089A1 (cs) |
ZA (1) | ZA929867B (cs) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5677291A (en) * | 1993-12-10 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
US5627172A (en) * | 1994-03-04 | 1997-05-06 | Natural Supplement Association, Incorporated | Method for reduction of serum blood lipids or lipoprotein fraction |
US5608095A (en) * | 1996-04-30 | 1997-03-04 | Hoechst Marion Roussel, Inc. | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
US5795876A (en) * | 1996-04-30 | 1998-08-18 | Hoechst Marion Rousssel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols |
US6114572A (en) * | 1996-11-20 | 2000-09-05 | Hoechst Marion Roussel, Inc. | Substituted phenols and thiophenols useful as antioxidant agents |
US6121463A (en) * | 1997-06-24 | 2000-09-19 | Hoechst Marion Roussel, Inc. | Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents |
US6133467A (en) * | 1997-06-25 | 2000-10-17 | Hoechst Marion Roussel, Inc. | 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol |
US6475526B1 (en) | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
US20080274209A1 (en) * | 2002-11-04 | 2008-11-06 | Integritas Pharma, Inc. | Methods of treating inflammation |
US6855341B2 (en) * | 2002-11-04 | 2005-02-15 | Jeffrey B. Smith | Anti-viral compositions and methods of making and using the anti-viral compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE271625C (cs) * | ||||
JPS52125170A (en) * | 1976-04-12 | 1977-10-20 | Yoshitomi Pharmaceut Ind Ltd | Pyridine derivatives |
DE3431004A1 (de) * | 1984-08-23 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung |
-
1991
- 1991-12-19 US US07/810,214 patent/US5254549A/en not_active Expired - Fee Related
-
1992
- 1992-12-17 TW TW081110130A patent/TW221289B/zh active
- 1992-12-17 CA CA002085687A patent/CA2085687A1/en not_active Abandoned
- 1992-12-17 IL IL10412392A patent/IL104123A/en not_active IP Right Cessation
- 1992-12-18 EP EP93900104A patent/EP0619807A1/en not_active Ceased
- 1992-12-18 MX MX9207427A patent/MX9207427A/es not_active IP Right Cessation
- 1992-12-18 WO PCT/EP1992/002946 patent/WO1993012089A1/en not_active Application Discontinuation
- 1992-12-18 AU AU31592/93A patent/AU662193B2/en not_active Ceased
- 1992-12-18 PL PL92304175A patent/PL171225B1/pl unknown
- 1992-12-18 JP JP5510638A patent/JPH07502271A/ja active Pending
- 1992-12-18 RU RU94031210A patent/RU2120938C1/ru active
- 1992-12-18 CZ CZ941352A patent/CZ283456B6/cs not_active IP Right Cessation
- 1992-12-18 ZA ZA929867A patent/ZA929867B/xx unknown
- 1992-12-18 HU HUP9401820A patent/HU215844B/hu not_active IP Right Cessation
-
1994
- 1994-06-17 FI FI942908A patent/FI942908A0/fi unknown
- 1994-06-17 NO NO942307A patent/NO301473B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
MX9207427A (es) | 1993-11-01 |
NO942307D0 (no) | 1994-06-17 |
PL171225B1 (pl) | 1997-03-28 |
FI942908A (fi) | 1994-06-17 |
IL104123A (en) | 1996-12-05 |
FI942908A0 (fi) | 1994-06-17 |
AU662193B2 (en) | 1995-08-24 |
JPH07502271A (ja) | 1995-03-09 |
CZ135294A3 (en) | 1995-11-15 |
HU215844B (hu) | 1999-04-28 |
US5254549A (en) | 1993-10-19 |
NO942307L (no) | 1994-06-17 |
TW221289B (cs) | 1994-02-21 |
AU3159293A (en) | 1993-07-19 |
HU9401820D0 (en) | 1994-09-28 |
CZ283456B6 (cs) | 1998-04-15 |
IL104123A0 (en) | 1993-05-13 |
EP0619807A1 (en) | 1994-10-19 |
RU2120938C1 (ru) | 1998-10-27 |
CA2085687A1 (en) | 1993-06-20 |
NO301473B1 (no) | 1997-11-03 |
WO1993012089A1 (en) | 1993-06-24 |
HUT70398A (en) | 1995-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0526824A3 (en) | Syringe sprayer | |
ZA92913B (en) | New beta-amino-alpha hydroxycarboxylic acids and ttheir use | |
EP0785806A4 (en) | DISPOSABLE SYRINGE | |
SG46569A1 (en) | Improved tubular bandage | |
GB2256146B (en) | Syringe | |
IL104123A0 (en) | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs | |
EP0511152A3 (en) | Quinoxaline compounds, their preparation and use | |
LTIP399A (en) | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs | |
ZA911956B (en) | 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances | |
AU1740692A (en) | New medicinal use | |
IL101880A0 (en) | Arylaminocarbonyl compounds,their preparation and their use as herbicides | |
GB9123204D0 (en) | New pharmaceutical use | |
GB9113943D0 (en) | New pharmaceutical use | |
GB9123202D0 (en) | New pharmaceutical use | |
GB9104269D0 (en) | New pharmaceutical use | |
GB9104307D0 (en) | New pharmaceutical use | |
GB9104306D0 (en) | New pharmaceutical use | |
GB9113918D0 (en) | New pharmaceutical use | |
GB9113850D0 (en) | New pharmaceutical use | |
GB9108749D0 (en) | New medical use | |
GB9104753D0 (en) | New medical use | |
GB9104825D0 (en) | New medical use | |
GB9204390D0 (en) | New pharmaceutical use | |
GB9204587D0 (en) | New pharmaceutical use | |
GB9023637D0 (en) | New pharmaceutical use |